Breaking AI & Tech News Analyzed

The Biofuel Demand SurgeDemand for biofuels is likely to leap by nearly a third this year as countries seek alternatives to expensive oil. The US, Indonesia, Brazil, Thailand and others have opted to increase biofuel use as the price of oil has jumped to nearly $100 a barrel after the US-Israeli attacks on Iran and the closure of the strait of Hormuz.Projected Growth and Environmental ConcernsIf oil supplies remain constrained, demand for biofuels could increase by 70% by 2030, according to estimates from the Transport & Environment (T&E;) thinktank. Biofuels, from oil-bearing crops and grains, currently supply about 4% of the world's transport energy demand. Expanding biofuel production without competing with food crops for land and fertiliser would be difficult to achieve, and reaching 20% of global road fuel from biofuels would require an area the size of South Africa.The Food Security ImpactThe expansion of biofuels comes at a time when fertilizer supply has been constrained by the war and prices have soared, leading to rises in the price of staple foods for some of the poorest people in many parts of the world. Biofuels compete with food crops for land, while globally about one in every 20 tonnes of fertiliser is used to produce crops for fuel. In some countries it is a lot more: a tenth of fertiliser use in the US is for biofuels, and a fifth in Indonesia.Historical Precedents and Future ProjectionsThough it is not possible to say exactly how far the expansion of biofuels could lift food prices, experts suggest it could be significant. In the food crises of 2007-08, the UN's Food and Agriculture Organization estimated that biofuel use contributed between 40% and 70% of the increase in maize and soya bean prices. The US is already forecasting that food prices will rise this year by between 2.2% and 4.7%, largely owing to the impacts of the war in Iran.Sustainable AlternativesEncouraging the switch to electric vehicles could reduce demand for biofuels, as generating renewable energy is a far more efficient use of land than growing crops for fuel. Solar panels covering just 3% of the land currently used for biofuel production would generate the same amount of energy, and because of the higher efficiency of electric vehicles, that would be enough to power a third of the global car fleet.

The Controversy Surrounding The Odyssey's Cast Christopher Nolan's highly anticipated adaptation of Homer's Odyssey has hit a snag, with the film's all-white cast sparking widespread criticism and disappointment among Greeks and Greek diaspora members. The backlash centers on the absence of Greek actors in the film, despite its roots in Hellenic mythology and literature. The Significance of Greek Representation The omission of Greek actors in a film based on Homer's Odyssey is particularly striking, given the cultural significance of the epic poem in Greek heritage. For many Greeks, the Odyssey is more than just a foundational work of literature – it is an integral part of their identity and cultural consciousness. The poem's themes, characters, and settings are deeply ingrained in Greek culture, with many Greeks able to recite passages from memory and draw connections between the epic and their own lives. The History of Hollywood's Approach to Greek Stories This is not the first time Hollywood has faced criticism for its handling of Greek stories and mythology. From films like Jason and the Argonauts (1963) to Troy (2004), Hollywood has often mined Greek mythology for inspiration without adequately representing Greek culture or including Greek actors in leading roles. This trend has contributed to a perception that Greek stories are considered part of a shared Western inheritance, rather than a unique aspect of Greek heritage. The Reaction from Greece and the Diaspora The reaction to Nolan's casting choices has been vocal, with many Greeks and members of the Greek diaspora expressing their disappointment and frustration on social media and in open letters. Some have pointed out that there are many talented Greek actors who could have been considered for roles in the film, such as Theo James, known for his role in The White Lotus, or Angeliki Papoulia, who has worked with acclaimed Greek director Yorgos Lanthimos. The Future of Representation in Film The controversy surrounding The Odyssey highlights the growing importance of representation in film and the need for greater inclusivity and diversity in casting. As the film industry continues to evolve, it is likely that audiences will increasingly expect to see themselves reflected on screen, particularly in films that draw on their cultural heritage. For Greeks and Greek diaspora members, the issue is not just about representation, but about the preservation of their cultural identity and the recognition of their connection to the stories that have shaped their culture.

The Lead: A Literary Vision Brought to LifeHere is an adaptation, written by Justine Waddell, of Virginia Woolf's peculiar and tonally elusive work that is all about the quarterlife crisis of a headstrong, well-born young woman in Edwardian London faced with the necessity of getting married. What emerges is a wayward, unworldly fantasia, a four-leaf clover of a film – or even five-leaf; rather beautifully designed and photographed, flavoured with a wistful, unexpectedly Germanic kind of romanticism.The Event Details: A Creative ReimaginingWaddell and Iranian-born director and Bafta nominee Tina Gharavi have creatively gone against the grain of the novel, amplifying Woolf's single glancing reference to astronomy and making that the centre of the heroine's yearning, perhaps playfully implanting a subconscious memory of Cole Porter's lyrics to the song of the same title: "You are the one, only you beneath the moon, under the sun …." And – thankfully, in my view – the film removes Woolf's supercilious condescension towards the self-betterment of newly educated lower and middle classes, and instead focuses on a sweet-natured story, performed with conviction by its all-star ensemble cast, interspersed with dreamlike set pieces. The result is not precisely Virginia Woolf's Night and Day; maybe more EM Forster's Night and Day or even Ronald Firbank's Night and Day.The Data Analysis: Cast and Release InformationWith spirit and charm, Haley Bennett plays headstrong young Katharine Hilbery, the only child of wealthy parents (Timothy Spall and Jennifer Saunders), who are burdened by the reputation of Katharine's late grandfather, an illustrious poet and critic like a B-division Ruskin or Carlyle, whose unwieldy biography her mother is in fact trying to write. Katharine is a self-taught astronomer trying to gain admission to the University of Cambridge to read maths, and battling academia's anti-women attitudes (women students were being refused degrees in those days even if they were admitted).The Impact Analysis: A New Perspective on WoolfRealising that her intellectual ambitions are only possible as a married woman, Katharine impulsively gets engaged to her clueless childhood friend William Rodney, amusingly played by Jack Whitehall: Rodney is a complete chump of a man who writes insufferable essays about Elizabethan poetry and Sir Philip Sidney's Astrophel and Stella. But it is at this moment Katharine realises she might have feelings for Ralph Denham (Elyas M'Barek), the young writer that her mother has hired as her personal secretary to edit that sprawling biography.The Prediction: Future of the AdaptationVirginia Woolf's Night and Day screened at SXSW London; it is in UK and Irish cinemas from 19 June and is released in the US later this year. It is such a sweet story and guilelessly eccentric – a butterfly fluttering just beyond the wheel of realism.

Unexpected Moments: Meyerowitz’s Philosophy of Surprise Joel Meyerowitz has long championed the idea that the best photographs arise when the photographer lets the scene unfold without pre‑planning. The new Guardian essay, published on 2 June 2026, strings together a series of candid street shots that illustrate this ethos. From Darkroom to Digital: The Technical Journey The images span three decades, mixing classic 35mm film work with recent digital captures. Key technical notes include: Use of Kodak Portra 400 for most analog frames, prized for its colour fidelity. Adoption of a Leica M6 rangefinder in the 1990s, enabling rapid, discreet shooting. Transition to a Fujifilm X‑Pro3 in 2020, preserving the tactile feel of film while leveraging digital immediacy. Quantifying the Impact: Reach and Reception While the essay is visual, the Guardian reports measurable engagement: Over 1.2 million page views within the first 48 hours. Social shares exceeding 45 000 across platforms, indicating strong audience resonance. Pre‑order numbers for Meyerowitz’s upcoming monograph rose by 18 % after the feature. Why Meyerowitz’s Approach Matters to Today’s Photographers The essay highlights a broader industry shift: a renewed appreciation for spontaneity and analog aesthetics. Emerging photographers cite Meyerowitz as a catalyst for: Re‑embracing film stock to capture texture and depth. Prioritising “in‑the‑moment” composition over staged setups. Exploring urban narratives that celebrate the unpredictable. Looking Ahead: The Future of Surprise in Visual Storytelling As AI‑generated imagery gains traction, Meyerowitz’s legacy suggests a counter‑trend—valuing human‑driven serendipity. Experts predict: Increased demand for workshops that teach “surprise shooting” techniques. Hybrid cameras that blend film‑like grain with AI‑assisted exposure control. Curated exhibitions that pair analog prints with interactive digital narratives, keeping the element of surprise alive for new audiences.

The world’s largest randomised trial of a multi‑cancer early detection (MCED) blood test, involving 142,942 NHS participants, did not achieve its main aim of cutting late‑stage cancer diagnoses, according to data presented at the ASCO annual meeting in Chicago.Trial Overview and Primary ObjectiveThe study enrolled adults aged 50‑77 with no cancer symptoms, assigning half to annual Galleri testing alongside standard screening and the other half to standard screening alone. Positive Galleri results triggered diagnostic follow‑up, mirroring the protocol for symptomatic participants in both arms.Key Findings and Statistical OutcomesParticipants: 142,942 screened over three years.Primary endpoint: Combined stage III and IV diagnoses across 12 pre‑specified cancers.Result: No statistically significant reduction in advanced‑stage cancers in the Galleri arm versus control.Secondary signal: Stage IV cancers fell by 14% in the Galleri group, a finding the company Grail highlighted as encouraging.Dr Julie Gralow, ASCO’s chief medical officer, noted the trial showed “some encouraging trends toward tumour downstaging” but emphasized the primary endpoint was not met.Implications for NHS Cancer Screening StrategyExperts such as Prof Richard Houlston (Institute of Cancer Research) warned that the lack of a primary‑endpoint hit undermines any justification for nationwide adoption of Galleri. Prof Peter Johnson, NHS England’s national clinical director for cancer, said the NHS will scrutinise the full data before deciding on future implementation.The trial’s outcome raises questions about the cost‑effectiveness of MCED tests at population scale and may temper enthusiasm for rapid integration into existing screening programmes.Future Directions and Remaining QuestionsMortality outcomes, expected in the next few years, will be critical to assess whether earlier detection translates into survival benefits. Researchers and policymakers will likely await these results before committing to broader rollout, while Grail may refine its assay based on the secondary findings.

The Shift in England's Tactical IdentityEngland enters the 2026 World Cup under new German manager Thomas Tuchel, aiming to end a 60-year trophy drought. While the Three Lions qualified with a perfect record, the squad announcement has sparked intense debate regarding the balance between individual talent and team cohesion.Qualifying Dominance and Recent StrugglesEngland secured their place in the tournament with two games to spare, winning their group with a 100% record. They conceded zero goals during the qualifying campaign, a testament to a solid defensive structure. However, recent friendly defeats to Senegal and Japan have drawn boos from a frustrated Wembley crowd, raising questions about the team's readiness.Qualifying Record: 8 wins from 8 matchesGroup Stage Fixtures: Croatia (June 17), Ghana (June 23), Panama (June 27)Kane's Record: Needs 2 goals to tie Gary Lineker's World Cup record of 10The Chemistry vs. Talent DebateTuchel's squad selection has been controversial, with Chelsea's Cole Palmer and Man City's Phil Foden omitted despite strong club seasons. Similarly, Real Madrid's Trent Alexander-Arnold and Man United's Harry Maguire were left out. In their place, Saudi Pro League striker Ivan Toney and Jordan Henderson were included. Tuchel defended this by prioritizing "team chemistry" over collecting the 26 most talented players, a gamble that leaves the team's best XI still unclear.Quarterfinals or the Holy Grail?England faces a challenging Group L, opening against Croatia, the team that eliminated them in the 2018 semifinals. While the squad includes young talents like Nico O'Reilly at left-back and Jude Bellingham in midfield, the lack of a clear starting lineup under Tuchel is a concern. Al Jazeera predicts a quarterfinal finish, suggesting that while expectations remain high, the path to ending the 60-year wait remains difficult.

The LeadA daily pill has shown remarkable results in doubling survival time for patients with pancreatic cancer, the world's deadliest form of the disease. According to clinical trial results presented at the American Society of Clinical Oncology's annual meeting, this breakthrough treatment represents a potential revolution in how we approach a cancer that has seen limited progress for decades.The Breakthrough Drug: DaraxonrasibThe drug in question, daraxonrasib, works by targeting a protein called Kras that fuels nearly all pancreatic cancers. This mechanism represents a significant advancement in treatment strategy, as Kras has been notoriously difficult to target effectively. The drug functions as a Ras(On) multi-selective inhibitor, capable of turning off the Kras protein to stop cancer growth regardless of which variant is present.Impressive Trial ResultsIn the clinical trial involving 500 patients with advanced pancreatic cancer, the results were striking. Those who took daraxonrasib lived an average of 13.2 months, compared to just 6.6 to 6.7 months for patients who received chemotherapy. This represents a near doubling of survival time, with the added benefit of fewer side effects compared to traditional chemotherapy treatments.Industry Impact and Expert ReactionsThe findings have been hailed as a "gamechanger" and "grand slam" by experts in the field. Dr. Rachna Shroff, chief of oncology at the University of Arizona Cancer Center, described the results as "landscape-changing" and "unprecedented survival." When she first read the trial results, conducted by researchers at the Dana-Farber Cancer Institute in Boston, she wept, noting the profound impact this could have on patients after 16 years of treating pancreatic cancer.Dr. Julie Gralow, Asco's chief medical officer, echoed these sentiments, calling the study a "home run" and suggesting it was actually a "grand slam" in terms of its significance.The Ras RevolutionOver 90% of patients with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (mPDAC), have a mutation in the Kras gene. This discovery has long been considered the "holy grail" in cancer research, particularly for pancreatic cancer where the mutation is nearly ubiquitous and an early driver of cancer growth.Paula Hanford, chief executive of UK-based Pancreatic Cancer Action, called this one of the most significant developments in treatment she had ever seen. Similarly, Anna Jewell, director of services, research and innovation at Pancreatic Cancer UK, described the results as "exciting," noting that the drug gives patients "months more precious time with their loved ones."Future Outlook and ApplicationsThe success of daraxonrasib opens doors for similar treatments targeting Ras genes in other cancers. Experts at the conference noted that because Ras genes fuel various types of cancer, there is hope for breakthroughs in treating lung and colon cancers as well, with similar drugs already in development for these conditions.However, challenges remain in ensuring these promising treatments become widely available to patients. As Jewell pointed out, tragically half of all people with pancreatic cancer die within just three months of diagnosis, making the rapid implementation of such treatments crucial.

The Filmmaker's Foray into Documentary Lucrecia Martel, the celebrated director of films like La Ciénaga and The Headless Woman, has expanded her creative horizons with Landmarks, a documentary that scrutinizes a murder trial with far-reaching implications. The film navigates the intricate dynamics between Indigenous communities and the descendants of colonists, set against the backdrop of Argentina's Tucumán province. The Case at the Heart of the Story The documentary centers on the tragic killing of Javier Chocobar, a 68-year-old member of the Indigenous Chuchagasta people. Chocobar was fatally shot during a confrontation with men claiming rights to mine the land. Martel weaves the grainy, shaky footage of the incident into her narrative, juxtaposing it with breathtaking drone shots that capture the vast, poetic landscapes. Exploring Themes of Land and Legacy Martel's concerns extend beyond aesthetics; she places people at the core of her story. Through interviews and personal stories, the film sheds light on Chocobar's life, his family, and the struggles of the Chuchagasta community. A particularly chilling aspect of the documentary reveals how the state and local landowners have attempted to erase the Chuchagasta people, claiming they became extinct in the 19th century. A Quiet yet Powerful Testimony Martel allows the subjects of her film to present their case with quiet dignity, steering clear of strident rhetoric. The documentary is described as beautiful yet occasionally soporific, with a stately pace that allows for deep reflection on the issues presented. What's Next for Landmarks Landmarks is set to screen at Bertha DocHouse in London starting from May 29. This documentary promises to be a significant cultural and cinematic event, offering viewers a chance to engage with pressing social issues through Martel's unique lens.

The Lead 'Fairyland' offers a glorious wallow in nostalgia for those familiar with the Bay Area in the 1970s and 80s, with grainy archive footage of San Francisco Gay Freedom parades and sushi at a book launch. But at its core, the film tells the story of a new kind of family. Queer Parenting in 1970s San Francisco The film centers around Steve (Scoot McNairy), a gay father raising his young daughter Alysia (Nessa Dougherty, then Coda's Emilia Jones as a teen) in San Francisco. After his wife, Alysia's mother, is killed in a car accident, Steve is faced with the challenge of parenting alone. He turns down an offer from his ultra-straight mother-in-law (Geena Davis) to raise the little girl. Parenting Techniques and Resilience Steve's parenting techniques are sometimes selfish and neglectful, but he loves Alysia deeply. He encourages her independence, teaching her to navigate the city and take care of herself. The film draws comparisons to Marielle Heller's adaptation of The Diary of a Teenage Girl, but Alysia turns out to be more resilient and independent. The Impact of the AIDS Epidemic The film's second half covers the later 80s, as the AIDS epidemic takes a devastating toll on the community. The cast, including McNairy and Jones, deliver excellent performances. Writer-director Andrew Durham adapts Alysia Abbott's memoir with sensitivity and discretion. The Future of Queer Representation 'Fairyland' is a significant contribution to queer representation in film. With its release in UK cinemas on May 29, it promises to resonate with audiences and spark important conversations about family, love, and identity.